Healthcare provider profile · identity verified

Elif N Erim, MD

Geriatric Medicine · UTICA, NY · NPI 1003842584

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	653	61
Eliquis	Apixaban	521	44
Atorvastatin Calcium	Atorvastatin Calcium	489	56
Sertraline Hcl	Sertraline Hcl	456	45
Levothyroxine Sodium	Levothyroxine Sodium	435	44
Metoprolol Succinate	Metoprolol Succinate	406	54
Pantoprazole Sodium	Pantoprazole Sodium	371	43
Omeprazole	Omeprazole	349	39
Potassium Chloride	Potassium Chloride	289	48
Amlodipine Besylate	Amlodipine Besylate	269	47
Gabapentin	Gabapentin	210	25
Escitalopram Oxalate	Escitalopram Oxalate	206	27
Torsemide	Torsemide	202	24
Losartan Potassium	Losartan Potassium	192	30
Allopurinol	Allopurinol	180	21
Tamsulosin Hcl	Tamsulosin Hcl	176	20
Metoprolol Tartrate	Metoprolol Tartrate	163	25
Januvia	Sitagliptin Phosphate	158	13
Finasteride	Finasteride	155	14
Buspirone Hcl	Buspirone Hcl	144	16
Lisinopril	Lisinopril	134	16
Clopidogrel	Clopidogrel Bisulfate	116	16
Metformin Hcl	Metformin Hcl	113	21
Tradjenta	Linagliptin	111	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	109	15
Latanoprost	Latanoprost	109	19
Donepezil Hcl	Donepezil Hcl	107	13
Mirtazapine	Mirtazapine	106	16
Carvedilol	Carvedilol	97	11
Famotidine	Famotidine	94	16
Bisoprolol Fumarate	Bisoprolol Fumarate	89	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	88	14
Entresto	Sacubitril/Valsartan	87	suppressed
Memantine Hcl	Memantine Hcl	84	11
Jardiance	Empagliflozin	78	suppressed
Cephalexin	Cephalexin	74	34
Lorazepam	Lorazepam	74	30
Morphine Sulfate	Morphine Sulfate	74	24
Spironolactone	Spironolactone	72	11
Fluoxetine Hcl	Fluoxetine Hcl	71	suppressed
Amiodarone Hcl	Amiodarone Hcl	69	suppressed
Pravastatin Sodium	Pravastatin Sodium	67	suppressed
Prednisone	Prednisone	66	22
Carbidopa-Levodopa	Carbidopa/Levodopa	65	suppressed
Linzess	Linaclotide	65	suppressed
Trazodone Hcl	Trazodone Hcl	64	suppressed
Risperidone	Risperidone	61	suppressed
Simvastatin	Simvastatin	58	suppressed
Hydralazine Hcl	Hydralazine Hcl	57	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	56	suppressed
Nystatin	Nystatin	55	21
Insulin Lispro Kwikpen U-100	Insulin Lispro	53	11
Methenamine Hippurate	Methenamine Hippurate	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	49	14
Aripiprazole	Aripiprazole	47	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	47	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	suppressed
Trulicity	Dulaglutide	44	suppressed
Timolol Maleate	Timolol Maleate	41	suppressed
Erythromycin	Erythromycin Base	38	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	11
Paricalcitol	Paricalcitol	38	suppressed
Rivastigmine	Rivastigmine Tartrate	37	suppressed
Ursodiol	Ursodiol	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	17
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Digoxin	Digoxin	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Incruse Ellipta	Umeclidinium Bromide	33	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	33	22
Arexvy	Rsvpref3 Antigen/As01e/Pf	32	31
Hydrocortisone	Hydrocortisone	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	30	suppressed
Scopolamine	Scopolamine	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	12
Mesalamine	Mesalamine	28	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	28	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	28	28
Vascepa	Icosapent Ethyl	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Telmisartan	Telmisartan	27	suppressed
Klor-Con M10	Potassium Chloride	24	suppressed
Midodrine Hcl	Midodrine Hcl	24	suppressed
Ozempic	Semaglutide	24	suppressed
Primidone	Primidone	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Baclofen	Baclofen	23	suppressed
Memantine Hcl Er	Memantine Hcl	23	suppressed
Metolazone	Metolazone	22	suppressed
Topiramate	Topiramate	22	suppressed
Gemtesa	Vibegron	21	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	21	suppressed
Ceftriaxone	Ceftriaxone Sodium	20	14
Dutasteride	Dutasteride	20	suppressed
Levemir Flexpen	Insulin Detemir	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Retacrit	Epoetin Alfa-Epbx	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Valsartan	Valsartan	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	17	suppressed
Lidocaine Hcl	Lidocaine Hcl	17	13
Ranolazine Er	Ranolazine	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Atenolol	Atenolol	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Haloperidol Lactate	Haloperidol Lactate	16	suppressed
Ramipril	Ramipril	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Anagrelide Hcl	Anagrelide Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Santyl	Collagenase Clostridium Hist.	13	suppressed
Brinzolamide	Brinzolamide	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Glipizide	Glipizide	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Loteprednol Etabonate	Loteprednol Etabonate	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Rhopressa	Netarsudil Mesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error